Vasisht Niraj
SVP & Chief Technology Officer at BIODELIVERY SCIENCES INTERNATIONAL INC
- Sold, on record
- $212k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Mar 23, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BIODELIVERY SCIENCES INTERNATIONAL INCSVP & Chief Technology Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BIODELIVERY SCIENCES INTERNATIONAL INCPlan not statedSep 23 2016
Sold 47,000 shares at $2.43 ($114k)
Vasisht Niraj, Chief Technology Officer
Sold 22.5% of holdings ($509k position)162,061 shares leftFirst sale on recordFiling
- 2 Form 4 sale BIODELIVERY SCIENCES INTERNATIONAL INCPlan not statedJan 30 +129 days
Sold 6,905 shares at $1.91 ($13k)
Vasisht Niraj, Officer
Sold 3.9% of holdings ($341k position)171,822 shares leftFiling
- 3 Form 4 sale BIODELIVERY SCIENCES INTERNATIONAL INCPlan not statedMar 1 +30 days
Sold 42,000 shares at $1.98 ($83k)
Vasisht Niraj, SVP & Chief Technology Officer
Sold 13.4% of holdings ($621k position)271,469 shares leftFiling
- 4 Form 4 sale BIODELIVERY SCIENCES INTERNATIONAL INCPlan not statedMar 23 +22 days
Sold 530 shares at $1.90 ($1k)
Vasisht Niraj, SVP & Chief Technology Officer
Sold 0.2% of holdings ($519k position)272,413 shares left0x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 23, 2017 | BIODELIVERY SCIENCES INTERNATIONAL INC | SVP & Chief Technology Officer | Form 4 sale | 530 | $1k | 0.2% | Plan not stated | SEC |
| Mar 1, 2017 | BIODELIVERY SCIENCES INTERNATIONAL INC | SVP & Chief Technology Officer | Form 4 sale | 42,000 | $83k | 13.4% | Plan not stated | SEC |
| Jan 30, 2017 | BIODELIVERY SCIENCES INTERNATIONAL INC | Officer | Form 4 sale | 6,905 | $13k | 3.9% | Plan not stated | SEC |
| Sep 23, 2016 | BIODELIVERY SCIENCES INTERNATIONAL INC | Chief Technology Officer | Form 4 sale | 47,000 | $114k | 22.5% | Plan not stated | SEC |